488 related articles for article (PubMed ID: 15016865)
1. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
[TBL] [Abstract][Full Text] [Related]
2. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail.
Jiang J; Aiken C
J Virol; 2007 Sep; 81(18):9999-10008. PubMed ID: 17609279
[TBL] [Abstract][Full Text] [Related]
3. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Murakami T; Ablan S; Freed EO; Tanaka Y
J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
[TBL] [Abstract][Full Text] [Related]
6. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
Murakami T; Freed EO
J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.
Wyma DJ; Kotov A; Aiken C
J Virol; 2000 Oct; 74(20):9381-7. PubMed ID: 11000206
[TBL] [Abstract][Full Text] [Related]
8. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
9. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
10. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
11. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
13. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
15. Maturation-induced cloaking of neutralization epitopes on HIV-1 particles.
Joyner AS; Willis JR; Crowe JE; Aiken C
PLoS Pathog; 2011 Sep; 7(9):e1002234. PubMed ID: 21931551
[TBL] [Abstract][Full Text] [Related]
16. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
Freed EO; Martin MA
J Virol; 1995 Mar; 69(3):1984-9. PubMed ID: 7853546
[TBL] [Abstract][Full Text] [Related]
17. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions.
Akari H; Fukumori T; Adachi A
J Virol; 2000 May; 74(10):4891-3. PubMed ID: 10775630
[TBL] [Abstract][Full Text] [Related]
18. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Kiernan RE; Ono A; Englund G; Freed EO
J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein.
Egan MA; Carruth LM; Rowell JF; Yu X; Siliciano RF
J Virol; 1996 Oct; 70(10):6547-56. PubMed ID: 8794289
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
